policy
Regenerative medicine, including therapeutic use of stem cells
Regenerative medicine holds promise in treating a variety of diseases, yet questions remain. The AVMA supports the continued scientific development of…
policy
Guidelines for use of autogenous biologics
Autogenous biological products may provide veterinarians a unique opportunity for control of certain infectious diseases when USDA-licensed commercial…
policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…
JAVMA news
FDA extends call for treatment limit ideas
Food and Drug Administration authorities have extended a call for ideas on how to limit durations of some approved antimicrobial treatments in…
JAVMA news
Researchers hope for blood-based canine cancer test in 2020
Company backing the technology struggles amid push for test validation
JAVMA news
New listings in AVMA Animal Health Studies Database
Below are some of the new listings of veterinary clinical studies in the AVMA Animal Health Studies Database.
AVMA news
Drug approved to treat dogs for chemotherapy-related diarrhea
Food and Drug Administration officials granted conditional approval in mid-December for the oral prescription drug Canalevia-CA1, the first drug with…